COVID-19 emerged as a global threat to human health and many organizations including pharma and biotech are working hard to find the treatments and cure against COVID-19. GenScript ProBio has an extensive experience and technical expertise in CDMO space and are trying our best to battle against COVID-19 pandemic.
We can accelerate DNA and RNA vaccine development for drug substance or drug product by providing raw materials or GMP plasmids for vaccine production.
*GenScript ProBio made several collaborations with many life sciences groups and pharma companies to develop antibodies against SARS-CoV2 using our Human Antibody Discovery Platforms such as Phage Display, Hybridoma and Single B-Cell Platform.
*To-date, we have screened more than 600 specific RBD (receptor-binding domain) binders and over 100 ACE2 (angiotensin-converting enzyme) blockers.
*We are also offering in vitro pseudovirus neutralization assays for further characterizing the antibodies against SARS-CoV2.
Now, our supply chain is in fully operation at its regular around-the-clock schedule. We have given high priority all the services related to COVID-19.
The pseudovirus neutralization assay can be used to test the neutralization effect of vaccine or therapeutic lead. We have optimized the pseudovirus designation, packaging, infection and assay workflow by analyzing COVID-19 infection mechanism in our BSL-2 laboratories.
In this webinar, we introduce single cell technology in immunology and antibody screening, including its emergence, various approaches, benefits, and the current state of its industrial applications. We also introduce background of COVID19, and GenScript ProBio ABD platform for COVID19 to accelerate your COVID19 antibody discovery.
A cell line platform can provide the best solution for the biopharmaceutical target. GenScript ProBio’s biologics platform can provide one-stop service of CMC for the biopharmaceutical target. In this webinar we introduce key technologies in cell line development and discuss how to achieve desired cell lines. We also share several cell line development case studies from GenScript ProBio.